Skip to main content
Quest Diagnostics

Advanced Multivariate Analysis to Discover Candidate RNA Biomarkers to Distinguish Relapsing-Remitting Multiple Sclerosis and Neuromyelitis Optica

CMSC 2024

Consortium of Multiple Sclerosis Centers

Nashville, TN, May 29- June 1, 2024

Poster presentation: Advanced Multivariate Analysis to Discover Candidate RNA Biomarkers to Distinguish Relapsing-Remitting Multiple Sclerosis and Neuromyelitis Optica

Authors: Sesler CL, Wylezinski LS, Shaginurova GI, Grigorenko EV, Cockerill FR, III, Racke MK, Spurlock CF, III

Specialty: Neurology

Related content

Publication
Multiple Sclerosis Followed by Neuromyelitis Optica Spectrum Disorder: From the National Multiple Sclerosis Society Case Conference Proceedings
Publication
Recurrent Optic Neuritis and Perineuritis Followed by an Unexpected Discovery: From the National Multiple Sclerosis Society Case Conference Proceedings
Publication
Machine Learning Analysis Using RNA Sequencing to Distinguish Neuromyelitis Optica from Multiple Sclerosis and Identify Therapeutic Candidates

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.